Hennion & Walsh Asset Management, Inc.
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1861642
Parsippany, NJ
Position in SUPN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$4,572,187
+$563,833 QoQ
Shares Held
88,454
+9.7% QoQ
Ownership
0.152%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hennion & Walsh Asset Management, Inc. holds $39,326,268 across 12 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (11.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
337,044 | $10,151,765 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
330,691 | $10,079,461 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
88,454 | $4,572,187 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
6,195 | $3,673,511 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
155,396 | $3,511,949 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
67,341 | $3,242,469 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
113,881 | $1,084,147 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
633,253 | $880,221 |
All Filings in SUPN
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,572,187 | 88,454 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $4,008,354 | 80,651 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $4,862,154 | 101,740 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $2,989,388 | 94,841 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $2,541,727 | 77,610 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $2,397,624 | 66,306 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,287,796 | 41,302 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,135,510 | 42,449 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,359,078 | 39,844 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $672,536 | 23,239 | Shares | Sole | 2024-01-10 | |
| 2022-09-30 | $4,124,114 | 121,835 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $3,722,524 | 128,718 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $6,550,682 | 202,682 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $6,328,944 | 217,042 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $6,534,736 | 245,022 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,788,884 | 252,968 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,586,992 | 251,604 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||